Sufentanil Infusion vs Intravenous Methadone for Postoperative Analgesia Following Head and Neck Dissection With Free Flap or Rotational Reconstruction

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-80
SponsorIndiana University

About this trial

The main purpose of this study is to determine which type of medication, sufentanil or methadone, is better at controlling pain during and, more importantly, after surgery in patients undergoing a head and neck dissection with free flap or rotational tissue reconstruction. Prior to their operation, subjects will be randomized to receive either Sufentanil or Methadone. After surgery, research staff will obtain information about recovery and pain levels.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

• Patients undergoing head and neck dissection with free flap or rotational reconstruction at Indiana University Health Adult Academic Health Center

ASA class 1, 2, or 3 (See Appendix)

Age 18 to 80

male or female

Disqualifiers

Any contraindication to opiates, (i.e. allergy to opioids, substance use disorder) as determined by PI review and any contraindications reported by the patient

Patient on home methadone at any dose

Any physical, mental or medical conditions which, in the opinion of the investigators, may confound quantifying postoperative pain resulting from surgery

Known true allergy to the study medications (sufentanil, methadone)

Trial design

Design model

Parallel

Treatments tested in this trial

  • sufentanil

    Drug

    1\. Intravenous sufentanil starting at a dose of 0.5 mcg/kg/min hr ideal body weight (IBW) at the beginning of the case, prior to surgical incision, with a discontinuation of the infusion when the surgical microscope is removed from the patient field and the closure of the incision(s) begins. (n=64)

  • methadone

    Drug

    2\. Intravenous methadone of 0.2 mg/kg IBW up to a maximum dose of 20mg, rounded to the nearest milligram. The methadone will be given at the beginning of the case, prior to surgical incision. n=64)

Treatment groups

128 Participants
are divided into 2 treatment groups
Group A: SufentanilOther 1 intervention
Group B: MethadoneOther 1 intervention

Trial outcomes

Primary outcomes

1

IV morphine equivalent

Cumulative milligrams IV morphine equivalent

Time frame
24 hours

Secondary outcomes

1

Opioid Consumption

Opioid Consumption and morphine equivalent (MME)

Time frame
1 hour after arrival time in post anesthesia care unit
2

Opioid Consumption

Opioid Consumption and morphine equivalent (MME)

Time frame
12 hour after arrival time in post anesthesia care unit
3

Opioid Consumption

Opioid Consumption and morphine equivalent (MME)

Time frame
24 hour after arrival time in post anesthesia care unit
4

Pain Scores

Visual analog scale (VAS) pain score on a scale of 1-10 (increments of 1 unit), 1 being no pain at all and 10 being the most pain the patient has ever experienced

Time frame
1 hour after arrival time in post anesthesia care unit

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.